GS, M., P, G., G, S., D, N., N, M., M, N., . . . DT, B. (2025). Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: Blood transcriptome analysis implicates the innate immunity and DNA damage response pathways. Annals of the rheumatic diseases, 84(2), 262. https://doi.org/10.1136/ard-2024-226051
Chicago Style (17th ed.) CitationGS, Moysidou, et al. "Molecular Basis for the Disease-modifying Effects of Belimumab in Systemic Lupus Erythematosus and Molecular Predictors of Early Response: Blood Transcriptome Analysis Implicates the Innate Immunity and DNA Damage Response Pathways." Annals of the Rheumatic Diseases 84, no. 2 (2025): 262. https://doi.org/10.1136/ard-2024-226051.
MLA (9th ed.) CitationGS, Moysidou, et al. "Molecular Basis for the Disease-modifying Effects of Belimumab in Systemic Lupus Erythematosus and Molecular Predictors of Early Response: Blood Transcriptome Analysis Implicates the Innate Immunity and DNA Damage Response Pathways." Annals of the Rheumatic Diseases, vol. 84, no. 2, 2025, p. 262, https://doi.org/10.1136/ard-2024-226051.
